Elman LB, et al. Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease. https://www.uptodate.com/contents/search. Accessed Feb. 16, 2023.
Preston DC, et al. Amyotrophic lateral sclerosis and its variants. In: Electromyography and Neuromuscular Disorders. 4th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed Feb. 16, 2023.
Elman LB, et al. Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease. https://www.uptodate.com/contents/search. Accessed Feb. 16, 2023.
Goldman L, et al., eds. Amyotrophic lateral sclerosis and other motor neuron diseases. In: Goldman-Cecil Medicine. 26th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Feb. 16, 2023.
Amyotrophic lateral sclerosis (ALS) fact sheet. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Amyotrophic-Lateral-Sclerosis-ALS-Fact-Sheet. Accessed Feb. 16, 2023.
Environmental factors. ALS Association. https://www.als.org/research/research-we-fund/scientific-focus-areas/environmental-factors. Accessed Feb. 16, 2023.
After the ALS diagnosis: Coping with the 'new normal.' ALS Association. http://www.alsa.org/als-care/resources/publications-videos/resource-guides/. Accessed Feb. 16, 2023.
Ami TR. Allscripts EPSi. Mayo Clinic. Dec. 22, 2022.
Dharmadasa T, et al. Genetic testing in motor neuron disease. Practical Neurology. 2022; doi:10.1136/practneurol-2021-002989.
Mehta P, et al. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2022; doi:10.1080/21678421.2021.2023190.
Relyvrio (approval letter). New Drug Application 216660. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process. Accessed Feb. 17, 2023.
Yamakawa M, et al. Demographics, clinical characteristics and prognostic factors of amyotrophic lateral sclerosis in Midwest. Muscle & Nerve. 2022; doi:10.1002/mus.27450.
Van Blitterswijk M, et al. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: Can we learn from other noncoding repeat expansion disorders? Current Opinion in Neurology. 2012; doi:10.1097/WCO.0b013e32835a3efb.
ALS certified centers and clinics. ALS Association. https://www.als.org/local-support/certified-centers-clinics?search_api_fulltext=Mayo+Clinic. Accessed Dec. 8, 2022.
Barry RL, et al. Ultra-high field (7T) functional magnetic resonance imaging in amyotrophic lateral sclerosis: A pilot study. NeuroImage Clinical. 2021; doi:10.1016/j.nicl.2021.102648.
Dorst J, et al. Clinical studies in amyotrophic lateral sclerosis. Current Opinion in Neurology. 2022; doi:10.1097/WCO.0000000000001099.
Oskarsson BE (expert opinion). Mayo Clinic. Jan. 6, 2023.
Sun Y, et al. An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics. 2023; doi:10.1080/14737175.2023.2174018.
Sturmey E, et al. Blood biomarkers in ALS: Challenges, applications and novel frontiers. Acta Neurologica Scandinavica. 2022; doi:10.1111/ane.13698.
Soga T, et al. Long-term outcomes after surgery to prevent aspiration for patients with amyotrophic lateral sclerosis. BMC Neurology. 2022; doi:10.1186/s12883-022-02619-z.
Rutkove SB, et al. Differential diagnosis of peripheral nerve and muscle disease. https://www.uptodate.com/contents/search. Accessed March 9, 2023.
National Amyotrophic Lateral Sclerosis (ALS) Registry. Centers for Disease Control and Prevention. https://www.cdc.gov/als/GeneralPublic_AboutRegistry.html. Accessed March 9, 2023.
Johnson SA (expert opinion). Mayo Clinic. March 8, 2023.
Staff NP (expert opinion). Mayo Clinic. March 9, 2023.
Oskarsson BE (expert opinion). Mayo Clinic. Feb. 21, 2023.